Eravacycline study for critically ill patients
Part of Infections clinical trials.
This study looks at how the drug eravacycline works in the body of critically ill patients whose first antibiotic didn't work. It aims to find the best dose to fight the infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old
- Your first antibiotic treatment stopped working for your infection
- You have been taking the study drug (eravacycline) for at least 3 days
- You do not have a urinary tract infection as your main infection
- You are not allergic to eravacycline or similar antibiotics (like tigecycline)
- You are expected to live longer than 48 hours
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well beta-lactam antibiotics (a common type of antibiotic) work in people being treated for infections at Imperial College NHS Trust. The information may help doctors make better dosing decisions.
This trial tests whether adding eravacycline to standard treatment can help clear a tough lung infection caused by bacteria that don't respond to many antibiotics. It's for adults with pneumonia who have already started eravacycline.
This Phase 2 study tests whether taking Xerava (an antibiotic) can prevent serious infections in people who have prolonged low neutrophils after chemotherapy or transplant preparation. If it works, it may lower the risk of infections during the highest-risk period after treatment.
This trial tests an antibiotic called eravacycline for children (ages 8–17) with serious belly infections. The medicine is given through an IV in the hospital to see if it is safe and tolerable.
This study tests a precise dosing approach for the antibiotic ceftazidime-avibactam to treat serious infections in ICU patients. It aims to help people with hard-to-treat bacteria that are resistant to many other antibiotics.
This trial compares different treatment options for patients in the ICU who have a resistant bacterial infection called Acinetobacter baumannii. If you have this infection after surgery, the study aims to find the best way to treat it.
Hear when a new Eravacycline trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.